Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.

MW, Tenforde; WH, Self; EA, Naioti; AA, Ginde; DJ, Douin; SM, Olson; HK, Talbot; JD, Casey; NM, Mohr; A, Zepeski; M, Gaglani; T, McNeal; S, Ghamande; NI, Shapiro; KW, Gibbs; DC, Files; DN, Hager; A, Shehu; ME, Prekker; HL, Erickson; MN, Gong; A, Mohamed; DJ, Henning; JS, Steingrub; ID, Peltan; SM, Brown; ET, Martin; AS, Monto; A, Khan; CL, Hough; LW, Busse; Lohuis CC, Ten; A, Duggal; JG, Wilson; AJ, Gordon; N, Qadir; SY, Chang; C, Mallow; C, Rivas; HM, Babcock; JH, Kwon; MC, Exline; N, Halasa; JD, Chappell; AS, Lauring; CG, Grijalva; TW, Rice; ID, Jones; WB, Stubblefield; A, Baughman; KN, Womack; CJ, Lindsell; KW, Hart; Y, Zhu; M, Stephenson; SJ, Schrag; M, Kobayashi; JR, Verani; MM, Patel

doi:10.15585/mmwr.mm7034e2

Public

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.

Shared by NobleBlocks on Aug 27, 2021 • 12:00 AM UTC

Authors:

Tenforde MW

Self WH

Naioti EA

Abstract

Real-world evaluations have demonstrated high effectiveness of vaccines against COVID-19-associated hospitalizations (1-4) measured shortly after vaccination; longer follow-up is needed to assess durability of protection. In an evaluation at 21 hospitals in 18 states, the duration of mRNA vaccine (P...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!